Generation Bio Co expected to post a loss of $2.85 a share - Earnings Preview

Generation Bio

01/08/2025 12:03

Generation Bio Co GBIO.OQ GBIO.O is expected to  show a fall in quarterly revenue when it reports  results on August 5 (estimated) for the period ending June 30 2025

The Cambridge Massachusetts-based  company is expected to report a 24.2% decrease in revenue to $3.1 million from $4.09 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Generation Bio Co is for a loss of $2.85 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Generation Bio Co is $75.00, about 94.1% above its last closing price of $4.44

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-2.98
-2.93
-2.20
Beat
25
Dec. 31 2025
-2.96
-3.01
-3.20
Missed
-6.2
Sep. 30 2024
-2.80
-2.83
-2.30
Beat
18.6​
Jun. 30 2024
-2.89
-2.78
-3.10
Missed
-11.3
​​Mar. 31 2024
-4.02
-4.08
-11.20
Missed
-174.4
Dec. 31 2023
-4.39
-4.49
-5.30
Missed
-18.2​
Sep. 30 2023
-5.03
-5.05
-4.30
Beat
14.9
Jun. 30 2023
-4.99
-4.97
-4.70
Beat
5.4

This summary was machine generated August 1 at 11:03 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)